REQUEST A DEMO
Total
USD $0.00
Search more companies

Ips Grupovivir Medicina Especializada S.A.S (Colombia)

Main Activities: Offices of Dentists
Secondary Activities: Ambulatory Health Care Services | Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Ips Grupovivir Medicina Especializada S.A.S Profile Updated: November 21, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Ips Grupovivir Medicina Especializada S.A.S is an enterprise located in Colombia, with the main office in Sincelejo. It operates in the Offices of Dentists industry. It was first established on October 24, 2017. In 2024, the company reported a net sales revenue increase of 8.07%. During that time, Ips Grupovivir Medicina Especializada S.A.S’s total assets grew by 45.56%. The net profit margin of Ips Grupovivir Medicina Especializada S.A.S increased by 0.49% in 2024.

Headquarters
Cra 17 Nro. 15 52 Es
Sincelejo; Sucre;

Contact Details: Purchase the Ips Grupovivir Medicina Especializada S.A.S report to view the information.

Basic Information
Registered Capital:
Purchase the Ips Grupovivir Medicina Especializada S.A.S report to view the information.
Financial Auditors:
Purchase the Ips Grupovivir Medicina Especializada S.A.S report to view the information.
Incorporation Date:
October 24, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Ips Grupovivir Medicina Especializada S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
8.07%
Total operating revenue
8.07%
Operating profit (EBIT)
30.58%
EBITDA
30.58%
Net Profit (Loss) for the Period
30.09%
Total assets
45.56%
Total equity
32.33%
Operating Profit Margin (ROS)
1.37%
Net Profit Margin
0.49%
Return on Equity (ROE)
-0.4%
Quick Ratio
3.03%
Cash Ratio
0.75%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?